These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 4862621)

  • 21. [Ambulatory therapy with morphazinamide in some forms of pulmonary tuberculosis of the primary cycle].
    La Mendola S; Polese I; Lo Verso Pedone A
    Minerva Med; 1965 Sep; 56(70):2836-44. PubMed ID: 5294986
    [No Abstract]   [Full Text] [Related]  

  • 22. [Study of hepatic function of patients with pulmonary tuberculosis treated with morphazinamide].
    Stupenengo RH; Martínez M
    Prensa Med Argent; 1966 Aug; 53(33):1808-11. PubMed ID: 5994109
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical results of piazofoline therapy in pulmonary tuberculosis].
    Deodato M
    Minerva Med; 1965 Sep; 56(71):2897-8. PubMed ID: 5322271
    [No Abstract]   [Full Text] [Related]  

  • 24. [Kidney function in patients with pulmonary tuberculosis during treatment with antitubercular agents, with special reference to pyrazinamide].
    Spychalski W; Grzegorzewska A; Westfal I
    Pneumonol Pol; 1987 Oct; 55(10):454-7. PubMed ID: 3438179
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effects of morphazinamide in the treatment of bronchial diseases in the course of tuberculosis].
    Bonarrigo N; Bonsignore G
    Minerva Med; 1965 Sep; 56(70):2811-8. PubMed ID: 5852639
    [No Abstract]   [Full Text] [Related]  

  • 26. [Morphazinamede alone or associated in treatment of recent and chronic pulmonary tuberculosis. Observations on 48 cases].
    Baroni V; Sidari A
    Minerva Med; 1965 Sep; 56(71):2864-72. PubMed ID: 5322581
    [No Abstract]   [Full Text] [Related]  

  • 27. [Morphazinamide by venous perfusion in therapy of pulmonary tuberculosis].
    Leoncini G; Bolondi O; Costi TF
    Minerva Med; 1965 Sep; 56(71):2910-3. PubMed ID: 5322275
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical observations on morphazinamide administered by intravenous perfusion in therapy of pulmonary tuberculosis].
    Lucchesi M; Pallotta G; Fantoli U
    Minerva Med; 1965 Sep; 56(71):2914-8. PubMed ID: 5322276
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effects of morphazinamide in monomedicamentous therapy per os and intravenously in pulmonary tuberculosis].
    Sorrentino F; Calagna L
    Minerva Med; 1965 Sep; 56(71):2938-42. PubMed ID: 5322280
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical experiences with morphazinamide administered in slow venous perfusion in the treatment of pulmonary tuberculosis].
    Censi G; Orlandini GC
    Minerva Med; 1965 Sep; 56(71):2881-92. PubMed ID: 5322269
    [No Abstract]   [Full Text] [Related]  

  • 31. [Determination of Mycobacterium tuberculosis' sensitivity to pyrazinamide on a BACTEC-960 bacteriological analyzer].
    Irtuganova OA; Smirnova NS; Slogotskaia LV
    Probl Tuberk Bolezn Legk; 2003; (7):40-2. PubMed ID: 12939878
    [No Abstract]   [Full Text] [Related]  

  • 32. [Results of therapy with morphazinamide administered orally in association with other antitubercular drugs].
    Curiale G; Tocco G
    Minerva Med; 1965 Sep; 56(71):2943-8. PubMed ID: 5322281
    [No Abstract]   [Full Text] [Related]  

  • 33. [Short-term treatment of tuberculosis with and without pyrazinamide in the second phase (TA-80)].
    Farga V; Valenzuela P; Yañez A; Valenzuela MT; Scheel G; Mendoza F; Torres E; Icekson I; Grinspun M; Fernández M
    Rev Med Chil; 1983 Jul; 111(7):750-4. PubMed ID: 6680460
    [No Abstract]   [Full Text] [Related]  

  • 34. [On the intrapleural and intrabronchial administration of morphazinamide administered alone and in association with dexamethasone 21-orthophosphate].
    Oncina E
    Minerva Med; 1965 Sep; 56(70):2818-20. PubMed ID: 5852640
    [No Abstract]   [Full Text] [Related]  

  • 35. [Level of blood serum level of uric acid in tuberculous patients treated with morphazinamide].
    Wawrzeńczyk B; Zaruski A
    Gruzlica; 1973 Feb; 41(2):177-80. PubMed ID: 4695789
    [No Abstract]   [Full Text] [Related]  

  • 36. Pyrazinamide deamidase activity in tuberculous disease.
    Gurumurthy P; Krishnamurthy PV; Garhupati Sarma G
    Am Rev Respir Dis; 1981 Jul; 124(1):97. PubMed ID: 7020509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Morphazinamide in the treatment of urinary tuberculosis].
    Torcello V; Cennamo L; Bianco A
    Minerva Med; 1965 Sep; 56(70):2820-7. PubMed ID: 5322266
    [No Abstract]   [Full Text] [Related]  

  • 38. [Tuberculostatic preparations of the 2d series in the clinical treatment of pulmonary tuberculosis].
    Kaminskaia AA; Utkin VV; Korotaev GA; Golitsina LV
    Probl Tuberk; 1967; 45(5):29-33. PubMed ID: 5617941
    [No Abstract]   [Full Text] [Related]  

  • 39. [Intravenous morphazinamide. Tolerance of the drug and therapeutic effects].
    Celotti A
    Minerva Med; 1965 Sep; 56(71):2892-7. PubMed ID: 5322270
    [No Abstract]   [Full Text] [Related]  

  • 40. Safety of rifampin and pyrazinamide for the treatment of latent tuberculosis infection.
    Stout JE
    Expert Opin Drug Saf; 2004 May; 3(3):187-98. PubMed ID: 15155147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.